Related Experiment Video
Updated: Apr 20, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Caring for patients with malignant pleural mesothelioma in Japan: evaluation of a Palliative Care Educational Program
Yasuko Nagamatsu1, Yukiko Nakayama, Helen Clayson
1St. Luke's International University, College of Nursing, Tokyo, Japan
Purpose:
This study evaluated the effect of an Educational PROGRAM on Palliative Care for MPM for Nurses in Japan.
Program:
The 5-h program consisted of lectures and care planning group work.
Materials And Methods:
This study used a pretest-posttest design with a single cohort of nurses and included a Difficulties in Palliative Care for Patients with MPM (DPCMPM) Scale with 15 items. The pre- and posttest scores were compared using a t-test.
Results:
We included 27 female nurses with a mean of 14.4 years of nursing experience. In 12 of 15 DPCMPM items, the posttest difficulty scores were lower than the pretest scores. Participants highly evaluated the program for validity, clarity, clinical usefulness, and the facilitators. The Palliative Care for MPM Handbook for Nurses was developed as an educational tool for clinical settings.
Conclusions:
The Educational PROGRAM on Palliative Care for MPM for Nurses was effective in reducing nursing difficulties.
Related Concept Videos
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Continuing Care
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

